Patent directory · USPTO A61K / A61P
Patents matching “Northwestern University”
565 pharma patents match "Northwestern University" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 565 pharmaceutical patents matching "Northwestern University" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10179114
Phenolic coatings and methods of making and using same
granted -
US 10167270
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
granted -
US 10167263
Treatment of amyotrophic lateral sclerosis
granted -
US 10167314
Methods of treating depression and other related diseases
granted -
US 10118938
Arsenoplatin anti-cancer agents
granted -
US 10111871
Nanoparticle drug delivery system and method of treating cancer and neurotrauma
granted -
US 10105366
Selective calcium channel antagonists
granted -
US 10098958
Delivery of oligonucleotide functionalized nanoparticles
granted -
US 10098893
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
granted -
US 10093668
Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)
granted -
US 10040799
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
granted -
US 10016499
Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
granted -
US 9993449
(S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma
granted -
US 9994817
Use of ligands for the programmed cell death receptor conjugated to solid supports for cultivating human regulatory T cells
granted -
US 9987242
Treatment of Levodopa-induced Dyskinesias
granted -
US 9980976
Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists
granted -
US 9980992
Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses
granted -
US 9981968
Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders
granted -
US 9968642
Compositions and methods for treatment of pain
granted -
US 9962448
Compounds and methods for targeted immune system delivery
granted -
US 9951014
Mammalian and bacterial nitric oxide synthase inhibitors
granted -
US 9931333
Compositions and methods for treating or preventing atrial fibrillation
granted -
US 9931418
Compositions for the delivery of RNA and drugs into cells
granted -
US 9925213
Nylon-3 co-polymers and synthetic lung surfactant compositions containing same
granted